Mechanism of Action of the Ribopyranoside Benzimidazole GW275175X against Human Cytomegalovirus

New human cytomegalovirus (HCMV) therapies with novel mechanisms of action are needed to treat drug-resistant HCMV that arises during therapy with currently approved agents. 2-Bromo-5,6-dichloro-1-β-d-ribofuranosyl-1H-benzimidazole (BDCRB) is an effective anti-HCMV agent with a novel mechanism of ac...

Descrizione completa

Dettagli Bibliografici

Pubblicato in:	Antimicrob Agents Chemother
Autori principali:	Underwood, Mark R., Ferris, Robert G., Selleseth, Dean W., Davis, Michelle G., Drach, John C., Townsend, Leroy B., Biron, Karen K., Boyd, F. Leslie
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	American Society for Microbiology (ASM) 2004
Soggetti:	Antiviral Agents
Accesso online:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC400548/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15105116/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.48.5.1647-1651.2004
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!